MEDICAMENTS FOR MANIPULATING T-CELL IMMUNE RESPONSE

Title:

MEDICAMENTS FOR MANIPULATING T-CELL IMMUNE RESPONSE

Document Type and Number:

WIPO Patent Application WO2000010595

Kind Code:

A3

Abstract:

The use of IFN alpha 21 in the manufacture of medicaments for use in activating Th2 helper cells is provided.

Inventors:

FOSTER GRAHAM RUSSELL (GB)
THOMAS HOWARD CHRISTOPHER (GB)

Application Number:

PCT/GB1999/002786

Publication Date:

May 25, 2000

Filing Date:

August 24, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

IMP COLLEGE INNOVATIONS LTD (GB)
FOSTER GRAHAM RUSSELL (GB)
THOMAS HOWARD CHRISTOPHER (GB)

International Classes:

A61K38/21; A61K39/39; A61P29/00; A61P33/02; A61P37/04; (IPC1-7): A61K38/21; A61K39/39; A61P29/00; A61P33/02; A61P37/04

Domestic Patent References:

WO1998033517A1	1998-08-06
WO1995024212A1	1995-09-14

Other References:

FOSTER G R ET AL: "Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency.", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, (1996 DEC) 16 (12) 1027-33., XP000876621

Download PDF:

View/Download PDF PDF Help

Previous Patent: USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS

Next Patent: VACCINE COMPRISING CYTOKINE-INDUCED HEAT SHOCK PROTEINS (HSP)